Last edition
News about "Morphic"
Lilly to Acquire Morphic to Enhance Outcomes for Patients with IBD
Eli Lilly and Company has signed a definitive agreement to acquire Morphic, a biopharmaceutical company developing oral integrin therapies for the treatment of serious chronic diseases.
Morphic | 09/07/2024 | By Aishwarya | 160
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members